Nancy M. Gray
31Patents
10h-index
17Co-inventors
68Inventor score
Filing activity: Oct 30, 1989 → Jan 14, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5474997A | Methods and compositions of (2R,4S) itraconazole for treating fungal yeast and dermatophyte infections | Human Necessities | 48 | Expired |
| US5985868A | Methods and compositions for treating androgen-dependant diseases using optically pure R-(-) casodex | Human Necessities | 42 | Expired |
| US5331000A | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen | Human Necessities | 40 | Expired |
| US5089506A | Ethanobicyclic amine derivatives for CNS disorders | Chemistry; Metallurgy | 30 | Expired |
| US5215992A | Ethanobicyclic amine derivatives for CNS disorders | Chemistry; Metallurgy | 28 | Expired |
| US5098916A | Propanobicyclic amine derivatives for CNS disorders | Chemistry; Metallurgy | 28 | Expired |
| US5698558A | Methods for treating allergic disorders using optically pure (-) cetirizine | Human Necessities | 19 | Expired |
| US5055468A | Use of bridged tricyclic amine derivatives as anti-ischemic agents | Human Necessities | 15 | Expired |
| US5627183A | Methods for treating urticaria using optically pure (+) cetirizine | Human Necessities | 14 | Expired |
| US5561151A | Antipyretic and analgesic methods of using optically pure R-etodolac | Human Necessities | 14 | Expired |
| US5618828A | Methods for treating gastro-esophageal reflux disease and emesis with optically pure (-) cisapride | Human Necessities | 10 | Expired |
| US6040307A | Methods ad compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections | Human Necessities | 10 | Expired |
| US5955478A | Methods for treating gastrointestinal motility dysfunction using optically pure (+) cisapride | Human Necessities | 10 | Expired |
| US5229413A | Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders | Human Necessities | 9 | Expired |
| US6066654A | Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride | Human Necessities | 9 | Expired |
| US5888535A | Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole | Human Necessities | 9 | Expired |
| US5629329A | Methods for treating disorders associated with the central nervous system using opticallly pure (+) cisapride | Human Necessities | 9 | Expired |
| US5955477A | Methods for treating gastrointestinal motility dysfunction using optically pure (--) cisapride | Human Necessities | 9 | Expired |
| US5137910A | Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders | Human Necessities | 8 | Expired |
| US5629328A | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (+) cisapride | Human Necessities | 8 | Expired |
| US5130330A | Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS disorders | Human Necessities | 7 | Expired |
| US5629337A | Methods for treating asthma using optically pure (-)-zileuton | Human Necessities | 6 | Expired |
| US6953808B2 | Method for treating gastric disorders using optically pure (−) pantoprazole | Human Necessities | 5 | Expired |
| US5508279A | Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia | Human Necessities | 5 | Expired |
| US5492933A | Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof | Human Necessities | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.